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Abstract
BACKGROUND: Sestamibi imaging is the most widely used pre-
operative localization study for patients with hyperparathyroid-
ism. Previous reports examine the relationship between the
weight and volume of excised parathyroid glands and preoper-
ative serum calcium and parathyroid hormone (PTH) levels. The
aim of this study was to examine whether these variables corre-
late with the results of preoperative Sestamibi scans.
MATERIAL AND METHODS: A retrospective review of 150 con-
secutive patients who underwent preoperative sestamibi imag-
ing for primary hyperparathyroidism between 1998 and 2007
was performed. Variables studied included patient demograph-
ics, diagnostic test (sestamibi) results, operative/pathology find-
ings and surgical outcome (normocalcaemia vs. persistent hy-
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percalcaemia). Sestamibi scans were designated as either “neg-
ative” (NSS) or “positive” (PSS), where PSS correctly localized
abnormal gland(s) enabling a focused neck exploration. The
results of sestamibi imaging were correlated with calcium/PTH
levels, weight/volume of excised glands and patient outcomes
and demographics.
RESULTS: Total excised gland weight/volume and preopera-
tive serum calcium levels were significantly higher with PSS (all,
p < 0.04). Higher preoperative serum calcium levels and great-
er total gland weight/volume were significantly associated with
successful operative outcome (presence of postoperative nor-
mocalcaemia; all, p < 0.01). Factors associated with operative
failure included multi-gland disease (p < 0.01) and NSS (p <
< 0.01). Higher diagnostic PTH levels (> 150 pg/mL) were as-
sociated with greater excised gland mass (p < 0.05) and vol-
ume (p < 0.05). Male gender was associated with higher pre-
operative serum calcium levels (p < 0.02). Of interest, patients
with single-gland disease had significantly higher preoperative PTH
levels than patients with multi-gland disease (155 vs. 109 pg/mL,
p < 0.05).
CONCLUSION: Positive sestamibi scans are associated with
heavier/larger parathyroid glands and higher preoperative se-
rum calcium levels. Male gender was associated with higher
preoperative serum calcium levels, while single-gland disease
was associated with higher preoperative PTH levels. In addi-
tion, successful surgical outcome was associated with higher
preoperative serum calcium levels and with greater excised par-
athyroid gland mass/volume. Surgical failure was associated
with multi-gland disease and negative sestamibi.
Key words: parathyroid hormone, PTH, sestamibi imaging,
minimally invasive radioguided parathyroidectomy, MIRP
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Introduction
Sestamibi imaging is the most frequently utilized preoperative
localization study for patients with primary hyperparathyroidism
[1, 2]. Studies comparing the relationship between volume and
weight of excised parathyroid glands and the diagnostic levels of
calcium and parathyroid hormone (PTH) have been previously
reported [1, 3–8]. However, there are no large series that investi-
gate the correlation between these variables and preoperative ses-
tamibi scan results [9].
The purpose of this study was to evaluate the relationship
between preoperative sestamibi scans and preoperative serum
calcium/PTH levels, excised parathyroid gland volume/weight, and
surgical outcome.
Material and methods
All patients who underwent preoperative sestamibi imaging at
our institution for biochemically proven primary hyperparathyroid-
ism between 1998 and 2007 were included in the study. We iden-
tified 150 patients from our hospital records. Data pertaining to
patient age, gender, diagnostic serum calcium and PTH levels,
weight and volume of the excised glands, and surgical outcome
were recorded. Weight and volume of excised parathyroid glands
were obtained from surgical pathology reports. The volume of each
gland was obtained by multiplying the three specimen dimensions
as listed on the pathology report. Total gland weight/volumes were
obtained by adding weights and volumes of all excised abnormal
parathyroid tissue for each patient.
The findings of the preoperative sestamibi scan were correlat-
ed with diagnostic criteria (serum calcium and PTH levels), oper-
ative findings (weight and volume of excised glands) and surgical
outcome (corrected hypercalcaemia versus persistent hypercal-
caemia). A successful outcome was defined as correction of hy-
percalcaemia postoperatively, while an unsuccessful outcome was
defined as persistent postoperative hypercalcaemia. Additional
comparisons included examinations of the pathology and bio-
chemical parameters when grouped by patient gender, age
(< 65 years vs. ≥ 65 years), single- versus multi-gland disease
and parathyroid hormone level (< 150 pg/mL vs. ≥ 150 pg/mL).
Double-phase sestamibi imaging was performed using a Gen-
eral Electric Millennium Gamma Camera (GE Medical Systems,
Waukesha, WI, USA). Patients were injected intravenously with
25–30 mCi technetium (Tc) 99m sestamibi. Planar imaging with
a 256 ¥ 256 matrix was performed with a low-energy, high-reso-
lution (LEHR) collimator 15 minutes after injection and 1.5–2 hours
later. Images were repeated at a preset time of 10 minutes, from
the level of the oropharynx to the top of the myocardium. A dou-
ble-phase study was considered “positive” for single or multiple
gland disease when foci of increased radiotracer uptake on initial
images persisted on delayed images. Whenever possible, the
exact location, side, upper or lower pole and suspected ectopic
parathyroid gland presence was identified and recorded.
All sestamibi scans were interpreted by a radiologist and sub-
sequently ranked according to a scale from 0 to 3 as follows:
0 — scans technically inadequate;
1 — scans technically adequate with no identifiable lesion
[i.e. negative scan];
2 — scans with moderate suspicion of a lesion [i.e. identified lat-
erality but not exact location of gland(s)];
3 — scans with high suspicion of a lesion [i.e. clearly identified
and localized abnormal gland(s)].
The sestamibi scan was considered “positive” (PSS) when
the scan correctly identified abnormal gland or glands (scan rank
2 or 3). This, in turn, enabled directed minimally invasive unilateral
exploration in cases of single-gland disease or limited bilateral
approach in cases of clearly defined bilateral disease. Converse-
ly, “negative” (NSS) scans did not clearly visualize abnormal
gland(s), and bilateral neck exploration was performed.
Statistical analysis was conducted using SPSS‘ for Windows‘
software and included c2 test, two-sample t-test, Mann-Whitney
U-test and coefficient of correlation, as appropriate. Statistical sig-
nificance was set at alpha = 0.05.
Results
One hundred and fifty patients with adequate preoperative
imaging studies were identified. The mean age was 59.4 ± 14.6
years (age range 20 to 93 years; median age 61.5 years). There
were 41 men and 109 women. Of note, men were significantly
younger (55.2 ± 13.2 years) than women (61.0 ± 14.9 years) at
the time of initial presentation (p < 0.03).
The preoperative sestamibi scan clearly indicated the location
of the gland(s) in 109 patients (PSS, scan rank 2 or 3). Of those,
nine patients (8%) had clearly defined multiple gland disease, with
6/9 (67%) confined to the same side and 3/9 (33%) located on
opposite sides of the neck. Unilateral exploration was performed in
106/109 patients (97%) and resulted in correction of hypercalcae-
mia in 103/106 cases (97%). Of the three failures, 1/3 had an initial
sestamibi scan showing unilateral two-gland disease and 2/3 pa-
tients had an initial sestamibi scan showing single-gland disease,
with 2/3 patients subsequently found to have small contralateral
abnormal glands and 1/3 found to have an ectopic upper medias-
tinal parathyroid gland. Three patients (3/109, or 3%) with PSS un-
derwent limited bilateral exploration due to the presence of well-
defined bilateral disease (≥ 2 glands clearly visualized on sestami-
bi), with 100% normocalcaemia, postoperatively.
In 41 patients, the sestamibi scan could not accurately local-
ize the abnormal lesion(s) (NSS, scan rank = 0 or 1), and formal
bilateral exploration was performed. Single-gland disease was
found in 27/41 patients (66%) and multiple gland disease in 14/41
(34%) patients upon bilateral exploration. In the NSS group, 26/27
(96%) of patients with single-gland disease and 8/14 (57%) of
patients with multi-gland disease were normocalcaemic postop-
eratively. Operative failures in the NSS group were attributed to
ectopic parathyroid gland location (3/7, 43%) or to glands that
were missed during the initial exploration (4/7, 57%).
Overall, hypercalcaemia was corrected postoperatively in 34/
/41 (83%) patients in the NSS group and in 16/23 (70%) patients
with multi-gland (≥ 2 gland) disease. This is in contrast to the
success rates seen with PSS (106/109, 97%) and with single-gland
disease (124/127, 98%). Consequently, factors associated with
operative failure included the presence of multi-gland disease
(p < 0.01) and initial negative sestamibi scan (p < 0.01).
The total excised gland weight correlated highly with total ex-
cised gland volume (R = 0.94; p < 0.01, Figure 1). Weight and
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volume of excised parathyroid glands significantly correlated with
PSS (both measurements, p < 0.04, Table 1). Both volume and
weight of glands removed from patients with PSS were approxi-
mately two times greater than volume and weight of glands re-
moved from patients with NSS. Serum calcium levels were noted
to be modestly higher for the PSS group (p < 0.04, Table 1). How-
ever, no significant relationship was found between diagnostic
PTH levels and the preoperative sestamibi scan.
The mean values of all studied variables except parathyroid
hormone were significantly higher in the group of patients in whom
hypercalcaemia was corrected (successful outcome) after neck
exploration compared with the small group of patients with con-
tinued hypercalcaemia (unsuccessful outcome, Table 2). Com-
paring successful with unsuccessful neck exploration, the differ-
ence between diagnostic calcium levels was modest (11.2 mg/dL
vs. 10.2 mg/dL, p < 0.01). The total excised parathyroid gland
volume and weight were between 3.0 to 3.7 times greater in the
successful outcome group than in the unsuccessful outcome
group (Table 2, both p < 0.01).
When comparing male and female patients, the only statisti-
cally significant difference noted was the preoperative calcium level
(Table 3). However, the small difference of 0.4 mg/dL is unlikely to
be of clinical significance. Of interest, when patients with single-
gland disease were compared to patients with multi-gland dis-
ease, preoperative parathyroid hormone levels were significantly
higher in the single-gland group (154.5 pg/dL) than in the multi-
gland group (108.8 pg/dL, p < 0.05) (Table 4). None of the pa-
rameters under study was significantly different when comparing
patients < 65 years old to those > 65 years old (Table 5).
A significant correlation was identified between both the vol-
ume and weight of excised glands and preoperative PTH levels
(Table 6). For patients with preoperative PTH > 150 pg/dL, the
excised glands were heavier and larger than for patients with pre-
operative PTH < 150 pg/dL (both, p < 0.05). For diagnostic calci-
um levels, these correlations were not identified.
Discussion
This study examines the relationship between preoperative
sestamibi scan and diagnostic calcium/PTH levels, the weight/
/volume of excised parathyroid glands, and postoperative out-
come. This study shares some similarities with other studies in
terms of patient demographics [10, 11] and the characteristics of
sestamibi imaging [1, 4, 8–10, 12]. While the overall reported ses-
Table 1. Correlation of preoperative sestamibi scan result (positive vs. negative) with diagnostic calcium and parathormone (PTH) levels
and weight/volume of excised glands
Scan designation Calcium [mg/dl]* PTH [pg/dl]* Total volume [cm3] Total weight [gm]
Positive (n = 109) 11.2 ± 0.746 147.6 ± 103.6 3.27 ± 4.89 1.48 ± 1.76
Negative (n = 41) 10.9 ± 0.806 147.0 ± 95.5 1.50 ± 1.42 0.861 ± 0.736
Significance p < 0.04 p = NS p < 0.03 p < 0.04
*intact PTH (normal range, 0–55 pg/ml); calcium (normal range, 8.4–10.2 mg/dl); NS — non significant
Table 2. Correlation between calcium, parathormone (PTH) and weight/volume of excised glands to outcome of neck exploration
Procedure outcome Calcium [mg/dl]* PTH [pg/dl]* Total volume [cm3] Total weight [gm]
Successful (n = 140) 11.2 ± 0.721 147.0 ± 103.0 2.94 ± 4.42 1.37 ± 1.61
Unsuccessful (n = 10) 10.2 ± 0.885 154.5 ± 73.4 0.785 ± 0.536 0.455 ± 0.308
Significance p < 0.01 p = NS p < 0.01 p < 0.01
*intact PTH (normal range, 0–55 pg/ml); calcium (normal range, 8.4–10.2 mg/dl); NS — non significant
Table 3. Correlation between patient gender and calcium, parathormone (PTH), weight/volume of glands
Patient gender Calcium [mg/dl]* PTH [pg/dl]* Total volume [cm3] Total weight [gm]
Male (n = 41) 11.4 ± 0.797 161.8 ± 122.2 2.62 ± 2.93 1.32 ± 1.06
Female (n = 109) 11.0 ± 0.745 142.0 ± 92.0 2.85 ± 4.73 1.31 ± 1.73
Significance p < 0.02 p = NS p = NS p = NS
*intact PTH (normal range, 0–55 pg/ml); calcium (normal range, 8.4–10.2 mg/dl); NS — non significant
Figure 1. Scatterplot showing the relationship between total excised par-
athyroid gland weight (x-axis) and total excised gland volume (y-axis).
The two variables demonstrated a very high degree of correlation.
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tamibi sensitivity ranges between 50% and 95%, it is important to
note that sestamibi imaging seems to be more sensitive for single
parathyroid adenomas (90%) compared to hyperplasia or double
adenomas (50–65%) [3, 13].
In our study, larger excised gland weight and volume correlat-
ed with PSS. Parathyroid glands excised from patients with PSS
had a significantly greater volume and weight than parathyroid
glands excised from patients with NSS. These findings are con-
sistent with those from previous studies [3, 4, 8]. In one study,
parathyroid glands identified with positive scans were ten times
heavier than those of negative scans [4]. In another, both weight
and volume were approximately two times greater for positive
scans, a finding more consistent with our observations [3].
When PSS and NSS were correlated to PTH levels, no statisti-
cally significant relationship was found. This finding is similar to
two other studies which showed no correlation between biochem-
ical parameters and scintigraphic results [3, 4]. In our series, pa-
tients with PSS had moderately higher calcium levels than those
with NSS, which is contrary to findings in other studies [3, 4]. How-
ever, it is unlikely that this small difference in diagnostic calcium
levels is clinically significant.
Three variables (total gland weight, total gland volume and
preoperative calcium level) were significantly higher in patients
with normocalcaemia after neck exploration than in patients with
continued hypercalcaemia (Table 2). Our clinical experience in-
dicates that patients with primary hyperparathyroidism are be-
ing diagnosed earlier in the course of the disease, and it may be
that parathyroid glands with lower mass and volume produce
lower levels of PTH and could be more difficult to identify diag-
nostically and intraoperatively. In addition, two of the three fail-
ures in the PSS group in this study were due to small, contralat-
eral glands that were not apparent on the preoperative sestami-
bi scan.
Preoperative parathyroid hormone levels were significantly
higher for patients with single-gland disease than for those with
multi-gland disease (Table 4). The fact that the total gland weight
and total gland volume were not significantly different between
single- and multi-gland disease groups poses an interesting ques-
tion from the standpoint of differences in PTH synthetic capacity
between these two groups. It is also noteworthy to mention that
when grouped by PTH levels (< 150 pg/mL vs. ≥ 150 pg/mL),
both total excised gland volume and total excised gland weight
were significantly greater in the higher PTH group, suggesting a
higher PTH output from larger and heavier parathyroid glands (Ta-
ble 6). Similar relationships were not true for calcium levels, per-
haps reflecting the complex metabolic interrelationships (renal,
bone and gastrointestinal tract metabolism) involved in metabolic
calcium processing [14].
While men had slightly higher diagnostic calcium levels, no sig-
nificant differences in PTH levels, total gland weight or total gland
volume were noted between men and women (Table 3). No signif-
icant differences were seen between patients < 65 years old and
those > 65 years old in any of the studied variables (Table 5).
Of note, this study did not utilize the intraoperative PTH mea-
surement as an adjunct to the MIRP technique. Nevertheless, our
success rates were comparable to those of other series, many of
which utilized intraoperative PTH as an intraoperative confirmato-
ry test. A group from the University of Louisville recently reported
overall operative success rates (98%) similar to ours (93%) with-
out the utilization of intraoperative PTH measurements [15].
Others, however, advocate the use of routine intraoperative PTH
determinations due to the reported operative failure rate of up to
Table 4. Calcium, parathormone (PTH), excised gland weight/volume for single vs. multiple adenomas
Number of glands Calcium [mg/dl]* PTH [pg/dl]* Total volume [cm3] Total weight [gm]
One (n = 127) 11.1 ± 0.758 154.5 ± 107.4 2.82 ± 4.33 1.30 ± 1.51
Two or more (n = 23) 11.0 ± 0.851 108.8 ± 36.1 2.66 ± 4.22 1.37 ± 1.94
Significance p = NS p < 0.05 p = NS p = NS
*intact PTH (normal range, 0–55 pg/ml); calcium (normal range, 8.4–10.2 mg/dl); NS — non significant
Table 5. Surgical outcome, calcium, parathormone (PTH), excised gland weight/volume grouped by patient age
Patient age Successful outcome (%) Calcium [mg/dl]* PTH [pg/dl]* Total volume [cm3] Total weight [gm]
< 65 (n = 88) 93.2% 11.1 ± 0.741 145.9 ± 82.4 2.81 ± 3.82 1.32 ± 1.42
≥ 65 (n = 62) 93.5% 11.1 ± 0.820 149.6 ± 123.7 2.77 ± 4.93 1.30 ± 1.79
Significance p = NS p = NS p = NS p = NS p = NS
*intact PTH (normal range, 0–55 pg/ml); calcium (normal range, 8.4–10.2 mg/dl); NS — non significant
Table 6. Correlation between preoperative parathormone (PTH) levels and preoperative calcium level as well as the weight/volume of excised
glands
PTH level [pg/dl]* Calcium [mg/dl]** Total volume [cm3] Total weight [gm]
< 150 (n = 97) 11.1 ± 0.742 2.27 ± 3.52 1.12 ± 1.26
≥ 150 (n = 53) 11.2 ± 0.828 3.75 ± 5.36 1.67 ± 1.99
Significance p = NS p < 0.05 p < 0.05
*intact PTH (normal range, 0–55 pg/ml); **calcium (normal range, 8.4–10.2 mg/dl); NS — non significant
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10% (7% in this study) [16]. While it may be that intraoperative
PTH levels may not be routinely needed, selective use of this tech-
nique should certainly be considered and investigated further. For
example, patients with NSS, multi-gland disease and those who
require re-exploration for persistent hypercalcaemia could benefit
from early intraoperative identification of persistent PTH elevation
due to the higher overall operative failure rates in these groups.
In addition, intraoperative use of the gamma probe proved to
be extremely useful in two reoperative cases following initial oper-
ative failures in this series. In one case, the gamma probe allowed
accurate identification of a 150 mg upper mediastinal parathyroid
gland. In another case, an ectopic parathyroid gland in the upper
neck was successfully localized using this technique.
The strengths of our study include its large sample size and
the high-quality complete dataset. The weaknesses of our study
include its retrospective nature, the lack of comparison to other
imaging/localization modalities (i.e. ultrasound) and the lack of
comparison of presence versus absence of intraoperative PTH
monitoring in determining operative success rates.
Conclusions
In this study, positive sestamibi scans correlated with greater
volume/weight of the excised parathyroid glands, as well as with
higher diagnostic calcium levels. Preoperative PTH levels > 150
pg/dL correlated with greater volume and weight of the excised
parathyroid glands. In addition, single-gland disease was associ-
ated with greater PTH levels than multi-gland disease. Successful
neck exploration was associated with higher diagnostic serum
calcium levels and with larger and heavier excised parathyroid
glands. Failure of operative therapy was associated with negative
initial sestamibi scan and with multi-gland disease.
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